These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 1792777)

  • 21. The appearance of pars planitis in multiple sclerosis.
    Vidović T; Cerovski B; Jukić T
    Coll Antropol; 2005 Jun; 29(1):203-6. PubMed ID: 16117323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Therapy of multiple sclerosis].
    Simó M
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):23-6. PubMed ID: 19731815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and toxicity of cyclosporine in chronic progressive multiple sclerosis: a randomized, double-blinded, placebo-controlled clinical trial. The Multiple Sclerosis Study Group.
    Ann Neurol; 1990 Jun; 27(6):591-605. PubMed ID: 2193613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical forms of chronic neuroinfections (organization of research, etiology and pathogenesis, therapeutic principles)].
    Umanskiĭ KG; Dekonenko EP; Shishov AS; Rudometov IuP; Andreeva LS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(3):71-7. PubMed ID: 6211017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple sclerosis and Natalizumab.
    Fiore D
    Am J Ther; 2007; 14(6):555-60. PubMed ID: 18090880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation of immunological studies and disease progression in chronic progressive multiple sclerosis.
    Trotter JL; Clifford DB; McInnis JE; Griffeth RC; Bruns KA; Perlmutter MS; Anderson CB; Collins KG; Banks G; Hicks BC
    Ann Neurol; 1989 Feb; 25(2):172-8. PubMed ID: 2521993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Multiple sclerosis--an immunological disease].
    Vedeler CA
    Tidsskr Nor Laegeforen; 1991 Mar; 111(8):944-7. PubMed ID: 2042210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-2 receptor and HLA class II antigens on cerebrospinal fluid cells of patients with multiple sclerosis and other neurological diseases.
    Tournier-Lasserve E; Lyoncaen O; Roullet E; Bach MA
    Clin Exp Immunol; 1987 Mar; 67(3):581-6. PubMed ID: 3038441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Use of a thymus polypeptide preparation to diagnose and correct immune deficiency states in multiple sclerosis].
    Golovkin VI; Ankhimova ES; Morozov VG; Khavinson VG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(2):179-82. PubMed ID: 6201026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A case of mixed connective tissue disease with lupus-like manifestations of the central nervous system, successfully treated with cyclophosphamide combined with prednisolone].
    Kuroki M; Okayama A; Kuwata G; Okamoto M; Tanaka G; Iga M; Kai Y; Matsuyama M; Murai K; Tsubouchi H
    Ryumachi; 2000 Jun; 40(3):627-32. PubMed ID: 10920688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in serum immunoglobulin concentrations in patients with multiple sclerosis during the treatment with ACTH.
    Maciejek Z; Rebeś Z; Kubasiewicz B
    Arch Immunol Ther Exp (Warsz); 1981; 29(2):141-4. PubMed ID: 6272663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparative analysis of the use of levamisole and pyrogenal in the treatment of multiple sclerosis].
    Mukhtarova AA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(3):366-7. PubMed ID: 3873154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The significance of a natural inhibitory factor in the pathogenesis of disseminated sclerosis].
    Dziuba AN; Frolov VM; Peresadin NA
    Lik Sprava; 1993; (2-3):93-5. PubMed ID: 8191750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The immunobiology of multiple sclerosis: an autoimmune disease of the central nervous system.
    Conlon P; Oksenberg JR; Zhang J; Steinman L
    Neurobiol Dis; 1999 Jun; 6(3):149-66. PubMed ID: 10408805
    [No Abstract]   [Full Text] [Related]  

  • 35. [IgG synthesis in the central nervous system in multiple sclerosis and other neurologic diseases. Measurement and validity].
    Safár J; Vymazal J; Tichý J; Růzicková V
    Cas Lek Cesk; 1985 Sep; 124(36):1131-6. PubMed ID: 4028102
    [No Abstract]   [Full Text] [Related]  

  • 36. [Oligoclonal aspects of IgG of the cerebrospinal fluid. Methods of analysis and clinical correlations].
    Uldry PA; Steck AJ; Regli F
    Schweiz Med Wochenschr; 1989 Jan; 119(2):49-54. PubMed ID: 2464847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of oral cyclophosphamide and prednisolone therapy on the endothelial functions and clinical findings in patients with early diffuse systemic sclerosis.
    Apras S; Ertenli I; Ozbalkan Z; Kiraz S; Ozturk MA; Haznedaroglu IC; Cobankara V; Pay S; Calguneri M
    Arthritis Rheum; 2003 Aug; 48(8):2256-61. PubMed ID: 12905480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Multiple sclerosis and psoriasis].
    Cendrowski W
    Wiad Lek; 1989 May; 42(9):575-8. PubMed ID: 2629326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies of autoimmunity in multiple sclerosis.
    Whitaker JN; Snyder DS
    CRC Crit Rev Clin Neurobiol; 1984; 1(1):45-82. PubMed ID: 6400508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunological disorders in patients with primary pulmonary hypertension].
    Chazova IE; Samsonov MIu; Kovalev VIu; Nasonov EL; Mareev VIu
    Ter Arkh; 1992; 64(9):70-2. PubMed ID: 1481160
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.